These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10257039)

  • 1. Considerations when proposing consultant pharmacist services to hospice programs.
    Whigham WD; Roberts KB
    Contemp Pharm Pract; 1982; 5(4):239-45. PubMed ID: 10257039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical services in hospices.
    Berry JI; Pulliam CC; Caiola SM; Eckel FM
    Am J Hosp Pharm; 1981 Jul; 38(7):1010-4. PubMed ID: 7258198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring new opportunities in hospice pharmacy.
    Martin CM
    Consult Pharm; 2009 Feb; 24(2):114-9. PubMed ID: 19275453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacist model of perceived responsibility for drug therapy outcomes.
    Planas LG; Kimberlin CL; Segal R; Brushwood DB; Hepler CD; Schlenker BR
    Soc Sci Med; 2005 May; 60(10):2393-403. PubMed ID: 15748686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
    Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
    Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospice program integration: an issue for policymakers.
    Paradis LF
    Death Educ; 1984; 8(5-6):383-98. PubMed ID: 10269326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey of hospice administrator and pharmacist perspectives on pharmacist services and the impact on medication requirements and cost.
    Latuga NM; Wahler RG; Monte SV
    Am J Hosp Palliat Care; 2012 Nov; 29(7):546-54. PubMed ID: 22218918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home health care: drug-related problems detected by consultant pharmacist participation.
    Cooper JW; Griffin DL; Francisco GE; Francis WR
    Hosp Formul; 1985 May; 20(5):643-5, 648-50. PubMed ID: 10271105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists.
    Franic D; Pathak DS; Mott D
    Pharm Pract Manag Q; 1999 Jul; 19(2):1-17. PubMed ID: 10558091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; MalĂ˝ J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospice development in a subacute care setting.
    Wilhelm ME; Wilhelm MA
    Hosp Prog; 1984 Feb; 65(2):42-5, 74. PubMed ID: 10315534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with epilepsy's perception on community pharmacist's current and potential role in their care.
    McAuley JW; Miller MA; Klatte E; Shneker BF
    Epilepsy Behav; 2009 Jan; 14(1):141-5. PubMed ID: 18984065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hospice in the care of terminally ill patients.
    Dome NH
    Radiol Technol; 1982; 53(4):313-6. PubMed ID: 7038759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug related problems pharmacists encounter when a patient is discharged from hospital].
    Leemans L; Peeters M; Vanderheyden Ch; Dupont AG; Leys M; Saevels J; Sarre S; Steurbaut S; Verrydt A; Veroeveren L
    J Pharm Belg; 2008 Dec; 63(4):94-102. PubMed ID: 19320132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses' communication of prognosis and implications for hospice referral: a study of nurses caring for terminally ill hospitalized patients.
    Schulman-Green D; McCorkle R; Cherlin E; Johnson-Hurzeler R; Bradley EH
    Am J Crit Care; 2005 Jan; 14(1):64-70. PubMed ID: 15608111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gap analysis: assessing the value perception of consultant pharmacist services and the performance of consultant pharmacists.
    Clark TR
    Consult Pharm; 2008 Sep; 23 Suppl C():3-15. PubMed ID: 19032018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal drug therapy: the role of the pharmacist in bridging the gap between knowledge and action.
    Hindmarsh KW
    Can J Clin Pharmacol; 2001; 8 Suppl A():53A-54A. PubMed ID: 11586381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior.
    Herbert KE; Urmie JM; Newland BA; Farris KB
    Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospice admission practices: where does hospice fit in the continuum of care?
    Lorenz KA; Asch SM; Rosenfeld KE; Liu H; Ettner SL
    J Am Geriatr Soc; 2004 May; 52(5):725-30. PubMed ID: 15086652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.